Sign in

Trevi Therapeutics, Inc.

Income Statement - Trevi Therapeutics, Inc. (TRVI)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.05 0.05 0.03 0.03 0.03 0.03 0.03 0.02 0.01 0.01
Operating income -0.05 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.01 -0.01
Non-operating income (net) 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.04 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.01 -0.01
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.04 -0.05 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.01 -0.01
Show Quarterly Income Statement

Income Statement - Trevi Therapeutics, Inc. (TRVI)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00
Operating income -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 -0.01 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 -0.01 0.00 0.00 0.00
4 days ago

Balance Sheet - Trevi Therapeutics, Inc. (TRVI)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total cash and short-term investments + 0.19 0.11 0.08 0.12 0.04 0.05 0.06 0.02 0.02 0.01
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.19 0.11 0.09 0.12 0.04 0.05 0.06 0.02 0.02 0.01
Total non-current assets + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.19 0.11 0.09 0.12 0.04 0.05 0.06 0.02 0.02 0.01
Total current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.02
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.01
Total liabilities 0.01 0.01 0.01 0.02 0.02 0.02 0.01 0.00 0.01 0.03
Total stockholders' equity + 0.18 0.10 0.08 0.11 0.02 0.03 0.05 0.02 0.01 -0.02
Common shares outstanding 145 101 99 65 23 18 18 9 9 16
Show Quarterly Balance Sheet

Balance Sheet - Trevi Therapeutics, Inc. (TRVI)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17
Total cash and short-term investments + 0.17 0.19 0.19 0.20 0.10 0.11 0.07 0.07 0.07 0.08 0.09 0.09 0.11 0.12 0.13 0.08 0.03 0.04 0.03 0.04 0.04 0.05 0.05 0.04 0.05 0.06 0.06 0.07 0.01 0.02 0.01 0.00 0.02 0.02
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.18 0.19 0.20 0.21 0.11 0.11 0.07 0.07 0.08 0.09 0.09 0.10 0.11 0.12 0.13 0.08 0.03 0.04 0.03 0.04 0.04 0.05 0.06 0.05 0.05 0.06 0.07 0.07 0.01 0.02 0.02 0.02 0.02
Total non-current assets + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 0.00
Total assets 0.18 0.19 0.20 0.21 0.11 0.11 0.07 0.07 0.08 0.09 0.10 0.10 0.12 0.12 0.13 0.08 0.03 0.04 0.03 0.04 0.04 0.05 0.06 0.05 0.05 0.06 0.07 0.08 0.02 0.02 0.02 0.02
Total current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01
Total stockholders' equity + 0.17 0.18 0.19 0.20 0.10 0.10 0.06 0.07 0.07 0.08 0.09 0.10 0.10 0.11 0.11 0.06 0.01 0.02 0.01 0.02 0.02 0.03 0.04 0.04 0.05 0.05 0.06 0.07 0.01 0.02 0.01 0.01 0.01
Common shares outstanding 146 146 145 130 118 106 101 101 100 99 99 99 99 98 69 60 31 22 22 20 19 19 18 18 18 18 18 18 18 18 9 9 9 13
4 days ago

Cash Flow - Trevi Therapeutics, Inc. (TRVI)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating cash flow + -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.01 -0.01
Cash flow from investing + -0.09 -0.02 0.06 -0.11 -0.11 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.12 0.06 -0.01 0.11 0.02 0.02 0.07 0.00 0.02 0.01
Change in cash -0.02 0.00 0.02 -0.02 -0.12 -0.01 0.05 -0.02 0.01 0.00
Show Quarterly Cash Flow

Cash Flow - Trevi Therapeutics, Inc. (TRVI)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17
Operating cash flow + -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00
Cash flow from investing + 0.02 -0.03 -0.05 0.00 -0.01 -0.02 0.01 0.00 -0.01 0.01 0.02 0.02 0.01 -0.05 0.00 -0.05 -0.05 -0.05 -0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.00 0.11 0.01 0.05 0.00 0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.06 0.06 0.00 0.01 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Change in cash 0.00 -0.04 -0.06 0.10 -0.01 0.02 0.00 0.00 -0.02 0.01 0.01 0.00 0.00 -0.05 0.04 0.00 -0.06 -0.05 -0.06 -0.01 0.00 -0.01 0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00
4 days ago

Trevi Therapeutics, Inc. (TRVI) - Shares Outstanding Diluted

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Dividend Payout

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Change In Inventory

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Net Income

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Trevi Therapeutics, Inc. (TRVI) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago